FDA Clearance Tracker · P150004-S044
NextGen DRG Lead Kit and Accessories
Last checked: Nov 20, 2026Latest source record: Jun 22, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Jun 22, 2021
Approved
Time to decision
176 days
Received Dec 28, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150004-S044
- Device name
- NextGen DRG Lead Kit and Accessories
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Plano, TX
- Received
- Dec 28, 2020
- Decided
- Jun 22, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150004
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for design changes to the delivery sheath and tunneling tool, including a new material and locking mechanism for the delivery sheath and a new handle and tip design for the tunneling tool, changes to the packaging configurations of the lead kit and accessories kit, and minor labeling changes to reflect the design and packaging changes. This supplement also requested approval for the addition of Microlumen, Inc. as the new supplier of the delivery sheath, Spectra Medical Inc. as the new supplier of the tunneling tool, and Xylem Company as an alternate supplier for the straight stylet.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
- EnSite X EP System510(k)
K261729 · Decided Sep 17, 2026 · 114 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
- TactiFlex Duo Ablation Catheter, Sensor Enabled (A-TFDM-D, A-TFDM-F, A-TFDM-J, A-TFDM-DD, A-TFDM-DF, A-TFDM-FF, A-TFDMPMA supplement
P220013-S028 · Decided Sep 4, 2026 · 186 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.